Education
About Us
Working with TipRanks
Follow Us
Sana Biotechnology (SANA)
NASDAQ:SANA
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -30.86M | $ -27.73M | $ -17.91M | $ -10.17M | $ -3.92M |
| Operating Income | $ -326.90M | $ -272.56M | $ -356.91M | $ -286.15M | $ -141.15M |
| EBITDA | $ -252.39M | $ -256.94M | $ -356.91M | $ -287.03M | $ -138.90M |
| Net Income | $ -283.25M | $ -266.39M | $ -344.18M | $ -278.64M | $ -130.78M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 205.19M | $ 434.01M | $ 746.88M | $ 412.00M | $ 138.98M |
| Total Assets | $ 565.30M | $ 822.72M | $ 1.13B | $ 730.30M | $ 415.70M |
| Total Debt | $ 104.10M | $ 108.25M | $ 110.94M | $ 71.91M | $ 48.21M |
| Net Debt | $ -29.42M | $ -68.51M | $ -142.09M | $ -340.09M | $ -31.82M |
| Total Liabilities | $ 277.79M | $ 323.40M | $ 400.90M | $ 1.15B | $ 558.24M |
| Stockholders' Equity | $ 287.51M | $ 499.31M | $ 728.50M | $ -421.18M | $ -142.54M |
| Cash Flow | |||||
| Free Cash Flow | $ -273.61M | $ -310.93M | $ -280.92M | $ -161.85M | $ -111.69M |
| Operating Cash Flow | $ -253.58M | $ -290.05M | $ -251.05M | $ -137.98M | $ -85.50M |
| Investing Cash Flow | $ 172.01M | $ 210.56M | $ -245.80M | $ -252.56M | $ -87.86M |
| Financing Cash Flow | $ 31.65M | $ 4.91M | $ 631.75M | $ 435.69M | $ 223.73M |